Scientists test new drug cocktail in fight against tough pancreatic cancer
NCT ID NCT00885066
Summary
This early-stage study tested a combination of three drugs—gemcitabine, capecitabine, and erlotinib—in patients with advanced pancreatic cancer that had worsened after initial treatment. The main goal was to find the highest dose patients could tolerate without severe side effects. Researchers also wanted to understand how the drugs interact in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
Conditions
Explore the condition pages connected to this study.